MBX

MBX Biosciences, Inc.

Healthcare · Biotechnology

$191.12 sample

+1.87 (+0.99%) 1D

Market cap

$910.6B

Price as of

2026-10-03

Latest filing

8-K · 2026-08-26

Alerts

8

Price$191.12 -2.83% 3M daily closessample

209.57189.25

2026-07-072026-07-292026-08-202026-09-102026-10-02

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Sep 23INSInsider sell: General Counsel
Sep 14INSInsider buy: EVP, Operations
Sep 09INSInsider buy: Chief Financial Officer
Aug 31INSInsider buy: Chief Financial Officer
Aug 26SEC8-K filed: material event
Aug 19INSInsider buy: Director
Aug 12INSInsider sell: Director
Aug 04INSInsider sell: Chief Financial Officer

Sign up to see the real MBX record →

Company facts

SEC EDGAR registration

Name: MBX Biosciences, Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -17sample, -100 to +100
Reporting currency: USD

Who is positioning in MBX

sample

Insiders: 30 insider transactions over 90 days, net selling, $568.4M
Congress: No member trades over 90 days
Institutions · 13F: 7 funds hold $8.8B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$37.6B +10.7% y/y

Q4 2024Q3 2026

Inventory$22.9B +13.4% y/y

Q4 2024Q3 2026

Accounts receivable$17.7B +12.5% y/y

Q4 2024Q3 2026

Total debt$48.1B +18.4% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $130.0B +5.6% 3M
Sample peer B: $170.6B -8.7% 3M
Sample peer C: $195.3B +12.8% 3M
Sample peer D: $278.2B +5.5% 3M
Sample peer E: $627.9B +16.1% 3M